1. Home
  2. DOUG vs INGN Comparison

DOUG vs INGN Comparison

Compare DOUG & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Douglas Elliman Inc.

DOUG

Douglas Elliman Inc.

HOLD

Current Price

$1.74

Market Cap

162.3M

Sector

Real Estate

ML Signal

HOLD

Logo Inogen Inc

INGN

Inogen Inc

HOLD

Current Price

$6.51

Market Cap

173.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOUG
INGN
Founded
1911
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Building operators
Industrial Specialties
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
162.3M
173.5M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
DOUG
INGN
Price
$1.74
$6.51
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$11.25
AVG Volume (30 Days)
339.8K
335.8K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
118.68
43.42
EPS
N/A
N/A
Revenue
$955,578,000.00
$348,668,000.00
Revenue This Year
N/A
$8.03
Revenue Next Year
N/A
$7.76
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.86
52 Week Low
$1.53
$5.34
52 Week High
$3.19
$9.13

Technical Indicators

Market Signals
Indicator
DOUG
INGN
Relative Strength Index (RSI) 47.69 51.58
Support Level $1.69 $6.00
Resistance Level $1.86 $6.77
Average True Range (ATR) 0.06 0.27
MACD 0.00 0.03
Stochastic Oscillator 44.83 80.00

Price Performance

Historical Comparison
DOUG
INGN

About DOUG Douglas Elliman Inc.

Douglas Elliman Inc is engaged in the real estate services business and seeks to acquire or invest in additional real estate services businesses. The Company also offers, through its subsidiaries and ventures, development marketing services and ancillary services, including mortgage, title, and escrow services. It generates revenue from commissions and other brokerage income, property management, and other ancillary services.

About INGN Inogen Inc

Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.

Share on Social Networks: